Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership

More documents

Recommendations

Info

14 GLOBAL DRUG FACILITY Diagnostics/ new diagnostics Expenditure on diagnostics/ new diagnostics for the Expand-TB Project funded by UNITAID increased by 52% between 2010 and 2011. The main reason for this increase is that the project, which was launched in 2009, was scaled up rapidly throughout 2011. By this time, challenges initially experienced in establishing laboratories and improving infrastructure had been addressed. 2008 $ 126 232 2009 $ 272 743 2010 $ 3 077 276 2011 $ 6 404 731 Figure 8 Value of diagnostics / new diagnostics procured by year (UNITAID funded) Supplemental costs Freight, procurement agents, quality control, insurance, pre-shipment inspection. The level of expenditure on supplemental costs associated with order placement remained relatively constant from 2010 to 2011. The major change was increased freight costs, due to increased quantities of drugs and diagnostics procured. Quality control costs were reduced significantly after February 2011, at which time a new policy was put in place: to cease 100% batch testing and instead to conduct randomised batch testing of 10% of all prequalified products and 20% of all Expert Review Panel (ERP) products. 1 1 For further explanation of the ERP, refer to Quality assurance section on page 16.
15 ANNUAL REPORT 2011 2010 2011 Freight $ 6 885 590 $ 8 333 093 Freight Agent Fee $ 5 322 781 $ 5 372 087 Agent Fee Quality Control $ 3 768 066 $ 2 492 758 Quality Control Insurance $ 483 897 PSI $ 399 985 $ 194 510 Insurance $ 437 706 PSI Figure 9 Supplemental costs comparison, 2010 / 2011 2010 2011 Advocacy $ 21 $ 23 Advocacy Quality Management System $ 56 $ 106 Quality Management System General Operating Costs $ 125 $ 112 General Operating Costs Meetings/Workshops $ 396 $ 147 Meetings/Workshops Travel GDF Staff $ 298 $ 180 Travel GDF Staff Expert Advice (TRC/BAC/BCG) $ 423 $ 302 Expert Advice (TRC/BAC/BCG) Missions and Desk Audits * $ 427 $ 543 Missions and Desk Audits * Expenditure ( in thousands of dollars ) *Consultant fees and travel costs Figure 10 Non-commodity expenditure, 2010 / 2011
Page 1 and 2: GLOBAL DRUG FACILITY ANNUAL REPORT
Page 3 and 4: Contents 02 | About the Global Drug
Page 5 and 6: 03 ANNUAL REPORT 2011 Message from
Page 7 and 8: 05 ANNUAL REPORT 2011 GDF was estab
Page 9 and 10: 07 ANNUAL REPORT 2011 Commodity exp
Page 11 and 12: 9 ANNUAL REPORT 2011 2010 GDF Grant
Page 13 and 14: 11 ANNUAL REPORT 2011 Historical an
Page 15: 13 ANNUAL REPORT 2011 80 70 60 Proc
Page 19 and 20: 17 ANNUAL REPORT 2011 There were ot
Page 21 and 22: 19 ANNUAL REPORT 2011 Diagnostics I
Page 23 and 24: 21 ANNUAL REPORT 2011 First-line dr
Page 25 and 26: 23 ANNUAL REPORT 2011 MDR-TB throug
Page 27 and 28: 25 ANNUAL REPORT 2011 Stockpile In
Page 29 and 30: 27 ANNUAL REPORT 2011 Key performan
Page 31 and 32: 29 ANNUAL REPORT 2011 Review • An
Page 33 and 34: 31 ANNUAL REPORT 2011 Monitoring mi
Page 35 and 36: 33 ANNUAL REPORT 2011 Annex 2 Patie
Page 37 and 38: 35 ANNUAL REPORT 2011 Country 2011
Page 39 and 40: 37 ANNUAL REPORT 2011 Country Suppl
Page 41 and 42: 39 ANNUAL REPORT 2011 WHO Region Co
Page 43 and 44: 41 ANNUAL REPORT 2011 Annex 5 GeneX
Page 45 and 46: 43 ANNUAL REPORT 2011 Countries rev
Page 48: Stop TB Partnership www.stoptb.org

Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership

Create successful ePaper yourself

Delete template?

Save as template?